Instrumento Inactivo

Otros idiomas Arena Pharmaceuticals, Inc. Nasdaq

Acciones

US0400471027

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement	19/09/22
Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)	16/03/22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index	15/03/22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P TMI Index	15/03/22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Global BMI Index	15/03/22
Pfizer Completes Acquisition of Arena Pharmaceuticals	14/03/22
Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals	11/03/22
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	11/03/22
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	11/03/22
Arena Pharmaceuticals, Inc. Announces Board Changes	11/03/22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Biotechnology Index	11/03/22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Composite Index	11/03/22
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..	11/03/22
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	10/03/22
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23/02/22
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23/02/22
Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue	23/02/22
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	23/02/22
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M	23/02/22
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23	23/02/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Arena Pharmaceuticals, Inc. Nasdaq

Acciones

US0400471027

Otros idiomas

Filtros